Research ArticleCOMPUTATIONAL BIOLOGY

Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors

+ See all authors and affiliations

Sci. Signal.  13 Aug 2013:
Vol. 6, Issue 288, pp. ra68
DOI: 10.1126/scisignal.2004008

This article has a correction. Please see:

Log in to view full text


Navigate This Article